Condition

Pulmonary Artery Hypertension

ClinicalTrials.gov condition label

Clinical trials30
Recruiting6
Common interventions25
Lead sponsors shown15

Clinical trials

30 shown
Sotatercept in Pulmonary Arterial HypertensionNCT07140484 · 2025-10-06
RECRUITING
Non-Invasive Measurements of Changes in Pulmonary Artery Pressure in Intensive Care Unit Patients Using Electrical Impedance Tomography - A Feasibility StudyNCT06544148 · 2024-08-05
RECRUITING
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO)NCT03138863 · 2024-05-01
RECRUITING
Potts-shunt for the Treatment of Pediatric Patients With Severe Pulmonary HypertensionNCT06429579 · 2024-04-23
RECRUITING
Right Ventricular Pacing in Pulmonary Arterial HypertensionNCT04194632 · 2021-01-01
RECRUITING
: Vascular Function in Health and DiseaseNCT02966665 · 2008-09-01
RECRUITING
Endothelial Cell Activation and Total Pulmonary Resistance in PAHNCT06035861 · 2026-08-01
NOT_YET_RECRUITING
REstoration of VItamin D in Pulmonary Arterial HypertensionNCT06258850 · 2024-07-01
NOT_YET_RECRUITING
Xenon MRI in Stable Pulmonary Hypertension (Jupiter AUGEAN)NCT06122922 · 2024-03-15
WITHDRAWN
High Altitude (HA) Residents With Pulmonary Vascular Diseases (PVD), 6 Minute Walk Distance (6MWD) Assessed at 2840m (HA) With and Without Supplemental Oxygen Therapy (SOT)NCT06003244 · 2023-09-23
UNKNOWN
HA Residents With PVD, SDB Assessed at HA (2840m) vs LA (Sea Level)NCT06072417 · 2023-09-22
UNKNOWN
HA Residents With PVD, Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) With and Without Supplemental Oxygen Therapy (SOT)NCT06084559 · 2023-07-05
UNKNOWN
HA Residents With PVD, 6MWD Assessed at HA (2840m) vs LA (Sea Level)NCT05996302 · 2023-07-05
UNKNOWN
Evaluation of Respiratory Muscle in Patient With Pulmonary Arterial HypertensionNCT05056532 · 2021-09-09
COMPLETED
Assessing the Repeatability of NT-proBNP Testing Using Laboratory and Point of Care Testing in PAHNCT05421949 · 2021-02-19
COMPLETED
GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)NCT04456998 · 2020-11-12
COMPLETED
Skeletal Muscle Mitochondrial Abnormalities and the Metabolic Syndrome in PAHNCT03979482 · 2019-06-01
COMPLETED
Cardiac Assessment by PV Loop in IPAH and Scleroderma PAHNCT04610788 · 2019-04-15
COMPLETED
Interventions Against Insulin Resistance in Pulmonary Arterial HypertensionNCT03617458 · 2018-08-23
COMPLETED
Impact of Aerobic Training on Sleep Quality and Aerobic Fitness in Male Patients With Pulmonary Artery HypertensionNCT04337671 · 2018-06-02
COMPLETED
Heart Catheterization Using Magnetic Resonance Imaging (MRI) Fluoroscopy and Passive GuidewiresNCT03152773 · 2017-08-02
TERMINATED
Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus InfectionNCT04094272 · 2017-07-01
COMPLETED
Retrospective Data Analysis of Data From the Zurich PH RegistryNCT03198910 · 2017-06-02
COMPLETED
A Study of Stellate Ganglion Block and / or Reserpine in Group 2 Pulmonary HypertensionNCT02684786 · 2016-07-01
WITHDRAWN
Assessment of Blood Coagulation Disorders in Patients With Pulmonary HypertensionNCT03195543 · 2015-03-12
UNKNOWN
Trimetazidine in Pulmonary Artery HypertensionNCT02102672 · 2014-03-01
UNKNOWN
Pulmonary Artery Involvement in Takayasu's ArteritisNCT03189602 · 2014-01-01
COMPLETED
Training With Whole Body Vibration Device in Patients With PAHNCT01763112 · 2013-01-01
UNKNOWN
Vascular Subphenotypes of Lung Disease in HIV & COPDNCT01581086 · 2012-01-01
COMPLETED
Is There Intravascular Hemolysis in Patients With Pulmonary Hypertension?NCT00502398 · 2007-09-01
UNKNOWN

Common interventions

PlaceboDRUG36-minute walk distance (6MWD) testOTHER16-minute walk distance (6MWD) test with supplemental oxygen (3 l/min, nasal)OTHER1Acetylcholine, Sodium Nitroprusside, Angiotensin-II, Norepinephrine, PhentolamineDRUG1Angiotensin-II, ValsartanOTHER1Assessment without intervention at High altitudeOTHER1BALT GoldbBAL2 Detachable BalloonDEVICE1BH4, L-NMMA, Vitamin C, Vitamin E, α-Lipoic Acid and L-AscorbateDRUG1Blood testPROCEDURE1BQ-123DRUG1BQ-123, MitoQ, BH4DRUG1Calcifediol Oral CapsuleDRUG1Catheter SystemDEVICE1Comprehensive therapy combined Potts-shunt procedure and conventional drug therapyPROCEDURE1Electrical impedance tomographyDEVICE1Endogenous thrombin potentialDIAGNOSTIC_TEST1Exercise groupOTHER1Exercise Group Galileo PAHDEVICE1Fexofenadine, RanitidineDRUG1GB002 (seralutinib)DRUG1Generic Dry Powder InhalerDEVICE1Hyperpolarized Xe129DRUG1lidocaineDRUG1Light transmission aggregometryDIAGNOSTIC_TEST1Maximum Exercise TestsOTHER1

Trial status mix

COMPLETED11
UNKNOWN8
RECRUITING6
NOT_YET_RECRUITING2
WITHDRAWN2
TERMINATED1

Phase mix

NA11
PHASE24
PHASE12
PHASE42

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.